Figure 7. AF: All-cause mortality with ximelagatran.

Figure 7AF: All-cause mortality with ximelagatran

From: RESULTS

Cover of Comparative Effectiveness of Warfarin and Newer Oral Anticoagulants for the Long-Term Prevention and Treatment of Arterial and Venous Thromboembolism
Comparative Effectiveness of Warfarin and Newer Oral Anticoagulants for the Long-Term Prevention and Treatment of Arterial and Venous Thromboembolism [Internet].
Adam SS, McDuffie JR, Ortel TL, et al.
Washington (DC): Department of Veterans Affairs (US); 2012 Apr.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.